Plasmid Construction
The plasmids used in this study are listed in Table S2 .
pDR198 was generated in a two-way ligation with an NheI-BamHI PCR product containing the extracellular domain of SpoIIP (oligonucleotide primers oDR386 and oDR387 and PY79 genomic DNA as template) and pRsetA (Invitrogen) cut with NheI and BamHI. pDR199 [his 6 -IID] was generated in a two-way ligation with an NheI-XhoI PCR fragment encoding the extracellular domain of SpoIID (oligonucleotide primers oDR379 and oDR380 and PY79 genomic DNA as template) and pRsetA cut with NheI and XhoI.
pCM187 [his 6 -IIP H189R
] was generated by site-directed mutagenesis using oligonucleotide primers oCM160 and oCM161 and plasmid pDR198 as template.
pCM188 [his 6 -IIP H278R
] was generated by site-directed mutagenesis using oligonucleotide primers oCM162 and oCM163 and plasmid pDR198 as template.
pCM189 [his 6 -IIP

D280G
] was generated by site-directed mutagenesis using oligonucleotide primers oCM164 and oCM165 and plasmid pDR198 as template. ] was generated by site-directed mutagenesis using oligonucleotide primers oDR734 and plasmid pDR199 as template.
pKM342 [his 6 -IID
R106A ] was generated by site-directed mutagenesis using oligonucleotide primers oDR738 and plasmid pDR199 as template.
pKM343 [his 6 -IID
T188A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR740 and plasmid pDR199 as template.
pKM344 [his 6 -IID
H297A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR744 and plasmid pDR199 as template.
pKM345 [his 6 -IID Y323A,Y324A ] was generated by site-directed mutagenesis using oligonucleotide primers oDR746 and plasmid pDR199 as template.
pKM346 [amyE::spoIID
E78A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR732 and plasmid pKM339 as template.
pKM347 [amyE::spoIID
Y80A ] was generated by site-directed mutagenesis using oligonucleotide primers oDR733 and plasmid pKM339 as template.
pKM348 [amyE::spoIID
E88A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR734 and plasmid pKM339 as template.
pKM349 [amyE::spoIID
E96A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR735 and plasmid pKM339 as template.
pKM350 [amyE::spoIID
K99A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR736 and plasmid pKM339 as template.
pKM351 [amyE::spoIID
Q101A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR737 and plasmid pKM339 as template.
pKM352 [amyE::spoIID
R106A ] was generated by site-directed mutagenesis using oligonucleotide primers oDR738 and plasmid pKM339 as template.
pKM353 [amyE::spoIID
T164A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR739 and plasmid pKM339 as template.
pKM354 [amyE::spoIID
T188A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR740 and plasmid pKM339 as template.
pKM355 [amyE::spoIID
Y201A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR741 and plasmid pKM339 as template.
pKM356 [amyE::spoIID
Y269A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR742 and plasmid pKM339 as template.
pKM357 [amyE::spoIID
S276A ] was generated by site-directed mutagenesis using oligonucleotide primers oDR743 and plasmid pKM339 as template.
pKM358 [amyE::spoIID
H297A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR744 and plasmid pKM339 as template.
pKM359 [amyE::spoIID
Q303A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR745 and plasmid pKM339 as template.
] was generated by site-directed mutagenesis using oligonucleotide primers oDR746 and plasmid pKM339 as template.
pKM361 [amyE::spoIID
Y171A
)] was generated by site-directed mutagenesis using oligonucleotide primers oDR747 and plasmid pKM339 as template.
pKM362 [amyE::spoIID
Y323A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR749 and plasmid pKM339 as template.
pKM363 [amyE::spoIID
Y324A
] was generated by site-directed mutagenesis using oligonucleotide primers oDR750 and plasmid pKM339 as template.
pTD68 [P T7 ::his 6 -sumo] was generated in a two-way ligation with an XbaI-XhoI PCR product containing the his 6 -SUMO domain (oligonucleotide primers oTB178 and oTB684 and pTB146 (Bendezu et al. 2009 )as template) and pET21a (Novagen) cut with XbaI and XhoI.
pTU204 [P T7 ::his6-sumo-sltY] was generated in a two-way ligation with an SacI-HindIII PCR product containing the extracellular domain of SltY (28-645aa) (oligonucleotide primers oTB773 and oTB774 and E. coli MG1655 genomic DNA as template) and pTD68 cut with SacI and HindIII. Figure S1 . Cell wall degradation activity of AmiD using Remazol brilliant blue coupled to E. coli PG. Reactions contained 4 µM of each protein. Activity was normalized to a reaction using Lysozyme. Halothermothrix orenii H 168. Conserved amino acids (black boxes) and similar residues (grey boxes) are highlighted. Amino acid substitutions that were tested are indicated above the sequence.
SUPPLEMENTAL FIGURE LEGENDS
Black circles indicate a strong block in engulfment and a >1000-fold defect in sporulation efficiency. Grey circles indicate aberrant engulfment as assessed by fluorescence microscopy.
White circles indicate alanine substitutions with no significant affect on engulfment or sporulation efficiency. Figure S9 . Morphological defects in the IID mutants. At hour 2 of sporulation, the indicated strains were analyzed by fluorescence microscopy using the membrane dye TMA-DPH. 
